Disease and treatment characteristics do not predict symptom occurrence profiles in oncology outpatients receiving chemotherapy

Abstract

Findings from the current study support the clinical observation that some oncology patients experience a differentially higher symptom burden during CTX. These high-risk patients experience significant decrements in quality of life.